Why the study?
Does renal denervation improve outcomes in patients with resistant hypertension and related chronic diseases driven by excessive central sympathetic drive?
Population
Patients with resistant hypertension and conditions linked by excessive central sympathetic drive
Design
Review
Authors
Loading...
May support sympathetic modulation across cardiometabolic diseases; leaves open randomized outcome trials before practice change.
Does renal denervation improve outcomes in patients with resistant hypertension and related chronic diseases driven by excessive central sympathetic drive?
Renal denervation may offer therapeutic benefits for a spectrum of chronic diseases characterized by excessive central sympathetic drive, including heart failure and metabolic syndrome components.
Sobotka et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: